Vous avez cherché: uimasti (Estonien - Anglais)

uimasti
narcotic

meelelahutuslik uimasti
recreational drug

uus sünteetiline uimasti
new synthetic drug

mis on uimasti lähteaine?
what is a drug precursor?

mitme uimasti narkootikumi koostarvitamine
polydrug use

riskide suurenemine mitme uimasti tarbimise korral
limits of the data available on polydrug use

peale uimasti tarbijaskond muutub sotsiaalselt eripalgelisemaks.
it is likely that in urban areas levels of use aresubstantially higher.

hispaania ja madalmaad on ka uimasti peamised jaotuskeskused.
prevalence and patterns of cocaine use

andmete esitamine mitme uimasti tarbimise probleemide kohta
the challenge of reporting polydrug use problems

enim esmase uimastina tarbitav uimasti on riigiti erinev.
the drug that is most commonly the primary drug of consumption varies between countries.

komisjon kutsub keelustama kogu elis amfetamiinilaadse uimasti 4-ma
commission calls for eu-wide ban on amphetamine-like drug '4-ma'

uimasti tootmisest on teatanud ka leedu, poola ja slovakkia.
production of the drug is also reported in lithuania, poland and slovakia.

kokaiinitarbijate jaoks võib see uimasti kujutada endast täiendavat terviseriski.
problem amphetamine and methamphetamine use is the topic of a selected issue that accompanies this annual report.

teave uue sünteetilise uimasti muu kasutuse ja selle ulatuse kohta,
information on other use of the new synthetic drug and the extent of such use,

euroopa uimastiprobleemide kontrollimise parandamine ja mitme uimasti tarbimise täpsem uurimine
improving monitoring of the drug problem in europe and improving the sensitivity to polydrug consumption

daniel retureau tuletas meelde, et tubakas on seadusega lubatud uimasti.
mr retureau reminded that tobacco was a legal drug.

8. peatükk: probleemse uimastitarbimise ja mitme uimasti tarbimise kontrollimise parandamine
chapter 8: improving the monitoring of problem consumption and multiple drug consumption

joonis 27: kanep kui peamine uimasti ravilolevate uutepatsientide hulgas 2002.aastal
figure 27: cannabis as reported primary drug among new clientsattending treatment in 2002

teave uue sünteetilise uimasti tuvastamise sageduse, asjaolude ja/või koguste kohta,
information on the frequency, circumstances and/or quantities in which a new synthetic drug is encountered,

eksperimentaalse või juhusliku kanepitarbimise vähenemine ei ole tingimata otseselt seotud uimasti regulaarse tarbimise suundumustega.
decreases in experimental or occasional use of cannabis are not necessarily directly related to trends in the regular use of the drug.